EyePoint Pharmaceuticals, Inc. (EYPT) Presents At Citi's Biopharma Back To School Conference Transcript

Question-and-Answer SessionSo obviously, a very busy time for the company. and for the wet AMD space. So I think just to start out, why don't you -- Jay, if you could spend just a few minutes just introducing the company, the therapy you're advancing, the key trials, obviously, in Phase III trials in wet AMD, and then we can get into a lot more detail from there.Jay DukerPresident, CEO & Director Sure. Thank you, and thanks, everybody, for coming. EyePoint does drug delivery to the back of the eye. We've ha ...